M. Metz

The delineation of target volumes for radiotherapy of lung cancer patients.

Michael Bremer, Elisabeth Weiss, Gabriele Beckmann, 2009, Radiotherapy and Oncology.

Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB.

L. Trümper, F. Griesinger, T. Schulz, 2004, Lung cancer.

Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium

M. Beckmann, A. Rosenwald, H. Einsele, 2022, Cancers.

Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial.

D. Rades, S. Schild, V. Rudat, 2018, Anticancer research.

Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: first results from a prospective multicenter German diagnostic study.

R. Schlenk, T. Brümmendorf, K. Götze, 2013, Leukemia research.

Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01).

D. Rades, S. Schild, A. Schreiber, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients

G. Egerer, M. Metz, A. Lorenz, 2021, Supportive Care in Cancer.

Patient-reported outcomes - secondary analysis of the SCORE-2 trial comparing 4Gy x 5 to 3Gy x 10 for metastatic epidural spinal cord compression.

D. Rades, S. Schild, B. Polat, 2019, International journal of radiation oncology, biology, physics.

Patient-reported symptoms during radiotherapy

M. Flentje, M. Metz, B. van Oorschot, 2017, Strahlentherapie und Onkologie.